Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma

PURPOSE: Patients with resected localized clear-cell renal cell carcinoma (ccRCC) remain at variable risk of recurrence. Incorporation of biomarkers may refine risk prediction and inform adjuvant treatment decisions. We explored the role of tumor genomics in this setting, leveraging the largest coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasudev, Naveen S., Scelo, Ghislaine, Glennon, Kate I., Wilson, Michelle, Letourneau, Louis, Eveleigh, Robert, Nourbehesht, Nazanin, Arseneault, Madeleine, Paccard, Antoine, Egevad, Lars, Viksna, Juris, Celms, Edgars, Jackson, Sharon M., Abedi-Ardekani, Behnoush, Warren, Anne Y., Selby, Peter J., Trainor, Sebastian, Kimuli, Michael, Cartledge, Jon, Soomro, Naeem, Adeyoju, Adebanji, Patel, Poulam M., Wozniak, Magdalena B., Holcatova, Ivana, Brisuda, Antonin, Janout, Vladimir, Chanudet, Estelle, Zaridze, David, Moukeria, Anush, Shangina, Oxana, Foretova, Lenka, Navratilova, Marie, Mates, Dana, Jinga, Viorel, Bogdanovic, Ljiljana, Kovacevic, Bozidar, Cambon-Thomsen, Anne, Bourque, Guillaume, Brazma, Alvis, Tost, Jörg, Brennan, Paul, Lathrop, Mark, Riazalhosseini, Yasser, Banks, Rosamonde E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Precision Medicine and Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068441/
https://www.ncbi.nlm.nih.gov/pubmed/36815791
http://dx.doi.org/10.1158/1078-0432.CCR-22-1936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068441/
https://www.ncbi.nlm.nih.gov/pubmed/36815791
http://dx.doi.org/10.1158/1078-0432.CCR-22-1936

Ejemplares similares